StockWatch
·
Pharmaceuticals
Loan & Debt18 Jun 2026, 03:43 pm

Cohance Lifesciences Promoters Pledge Shares for $285M Loan

AI Summary

Cohance Lifesciences Limited (formerly Suven Pharmaceuticals) has disclosed that its promoters, Jusmiral Holdings Limited and Berhyanda Limited, along with their respective holding entities Jusmiral Midco Limited and Berhyanda Midco Limited, have encumbered their shares. This action is in relation to a USD 285 million term loan facility. Jusmiral Holdings Limited has pledged 80,434,990 shares (21.02% of total capital), and both promoters have agreed to covenants restricting disposal and security creation on their shareholdings. The total promoter holding in Cohance Lifesciences is 57.49%.

Key Highlights

  • Promoters of Cohance Lifesciences have encumbered shares for a USD 285M loan.
  • Jusmiral Holdings pledged 80.4M shares (21.02% of total capital).
  • Total promoter holding stands at 57.49% of the company's share capital.
  • Encumbrances include share pledges and restrictive covenants.
  • The loan facility impacts the shareholding of Jusmiral Holdings and Berhyanda Limited.